Alys Pharmaceuticals launches with $100m financing from Medicxi to advance immuno-dermatology focused pipeline 13-Feb-2024 By Isabel Cameron Alys Pharmaceuticals, an immuno-dermatology focused company, has launched with $100 million financing by Medicxi and an R&D pipeline enabled by multiple platform technologies.
Will biotech see an uptick in M&A? 19-Jul-2022 By Rachel Arthur The biopharma M&A market has slowed since 2019. But is a buyer’s market emerging?
ElevateBio closes $170m Series B financing round 09-Apr-2020 By Ben Hargreaves The accelerator for cell and gene therapy startups reveals the closure of its second financing round and how the funds will be used.
